Last reviewed · How we verify

NCT05701969

Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift

Status unknown EARLY_PHASE1 Last updated 23 October 2023
What this trial tests

EARLY_PHASE1 trial testing Melatonin in Sleep Disorders, Circadian Rhythm in 50 participants. Status unknown.

Timeline
30 May 2022
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorUniversity of Virginia
PhaseEARLY_PHASE1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment50
Start date30 May 2022
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Virginia

Who can join

18 and older, any sex, with Sleep Disorders, Circadian Rhythm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Anesthesiology residency requires extended and overnight shifts, which may negatively impact the quantity and quality of sleep. Previous studies have investigated the effect of night float shift work on anesthesiology resident sleep and performance and demonstrated that total sleep quantity and time spent in deep and rapid eye movement (REM) sleep were significantly reduced during night float and did not return to baseline after 3 nights of recovery. Melatonin is a hormone produced by the pineal gland, which regulates the circadian rhythm that governs sleep. Exogenous melatonin may be used as a sleep aid and is available over the counter in the United States. Melatonin is effective in realigning the circadian rhythm disorder caused by night shift work and increasing sleep duration; however, melatonin's effect on improving sleep in resident trainees has not been investigated. The investigators propose a prospective double-blinded randomized control trial to investigate the effect of melatonin on sleep quantity and quality in resident physicians assigned to a night float system.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Circadian clocks and their role in kidney and eye diseases across organ systems.
    Chen X, Zhang W, Gu Y, Huang S. · · 2025 · cited 3× · PMID 40496242 · DOI 10.3389/fphys.2025.1583502

Verify or expand the search:

Other trials of Melatonin

Trials testing the same drug.

Other recruiting trials for Sleep Disorders, Circadian Rhythm

Currently open trials in the same condition.

Other University of Virginia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05701969.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing